INTAS THIRD PARTY SALES 2005, S.L.

Italy

All drugs from this manufacturer

  • NINTEDANIB INTAS

    This medicine is used in adults for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, and interstitial lung disease associated with systemic sclerosis (SSc-ILD). It helps to reduce the further appearance of scarring and the stiffening of the lungs.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    nintedanib esilate -

    ATC: L01EX09

  • It is prescribed to adults who have had a heart attack more than a year ago or who suffer from unstable angina. It is used to reduce the risk of a new heart attack, stroke, or death from heart or vascular disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ticagrelor -

    ATC: B01AC24